col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


9 Results       Page 1

 [1] 
Medknow Publications: Journal of Pharmacology and Pharmacotherapeutics
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―10 Cost-effectiveness and Side Effects of Using Heparin and Enoxaparin as a Treatment for COVID-19-associated Coagulopathy Nurul Iska Ulmarika Idris, Abdul Khairul Rizki Purba, Arifa Mustika, Anna Surgean Veterini, Mochamad Yusuf Alsagaff, Mohammad Qorib
2 [GO] 2023―Jan―31 Targeting TLR-4 Signaling to Treat COVID-19-induced Acute Kidney Injury Meaad A. Almazmomi, Mohammed Alsieni
3 [GO] 2023―Jan―19 Delayed Extensive Local Reaction to the mRNA-1273 Vaccine against SARS-CoV-2: A Case Report Renato Ferreira-da-Silva, Inês Ribeiro-Vaz, Ana Marta Silva, Fernando Nunes, Manuela Morato, Jorge Junqueira Polónia, Paulo Guedes
4 [GO] 2022―Dec―02 Progress Update on the Epidemiology of COVID-19 Variants and the Assessment Status of Developed Vaccines Katharigatta N. Venugopala
5 [GO] 2022―Jul―07 Adverse Drug Reactions with Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis Smrati Tiwari, Zahaan Vakil
6 [GO] 2022―May―04 COVID-19 and Substance Use: A Scientometric Assessment of Global Publications During 2020 and 2021 Sandeep Grover, B.M. Gupta, K.K. Mueen Ahmed
7 [GO] 2021―Nov―24 A mini review: Mucormycosis in coronavirus disease-19, host-iron assimilation, and probiotics as novel therapy Ankit Bhardwaj, Vandana Roy, Indu Priyadarshini
8 [GO] 2021―Nov―24 2-deoxy-d-glucose: A ray of hope in covid pandemic DhritiKumar Brahma, Priyotosh Banerjee, IndraniDevi Sarma, DasguptaHimadri Sekhar, Melambha Surong
9 [GO] 2020―Sep―11 Critical review and analysis of approval of favipiravir for restricted emergency use in mild-to-moderate COVID-19 Arunkumar Radhakrishnan, Ruckmani Arunachalam, Abinaya Elango
 [1] 

9 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec